2D |
(two-dimensional) |
3D |
(three-dimensional) |
ADAMs |
(disintegrin and metalloproteinases) |
ADAMTS |
(thrombospondin motifs) |
ASKVKV |
(Ala-Ser-Lys-Val-Lys-Val) |
BFGF |
(fibroblast growth factor) |
BM |
(basement membranes) |
BMP |
(bone morphogenetic protein) |
CXCL |
(C-X-C motif ligand) |
CAC |
(colitis-associated colon cancer) |
CAFs |
(cancer-associated fibroblasts) |
COMP |
(cartilage oligomeric matrix protein) |
COX-2 |
(cyclooxygenase 2) |
CRC |
(colorectal cancer) |
CRLM |
(colorectal liver metastasis) |
DAMPs |
(damage-associated molecular patterns) |
DDR |
(DNA damage response) |
DDrs |
(discoidin domain receptors) |
dECM |
(decellularized ECM) |
DEFA3 |
(Defensin Alpha 3) |
EAC |
(esophageal adenocarcinoma) |
EBP |
(elastin binding protein) |
ECM |
(extracellular matrix) |
ED-A and ED-B |
(extra domain A-B) |
EGF |
(epidermal growth factor) |
EHS |
(Engelbreth-Holm-Swarm) c |
EMT |
(epithelial to mesenchymal transition) |
EP |
(E-type prostanoid) |
ERK |
(extracellular-regulated kinase) |
FAK |
(focal adhesion kinase) |
FGF-2 |
(fibroblast growth factor) |
FMLP |
(formyl met-leu-phe) |
FOLFIRI |
(folinic acid, fluorouracil acid and irinotecan) |
FOLFIRINOX |
(folinic acid, fluoruracil acid, irinotecan and oxaliplatin) |
GAGs |
(glycosaminoglycans) |
GLUT |
(glucose transporters) |
GM-CSF |
(Granulocyte-Macrophage Colony-Stimulating Factor) |
HA |
(hyaluronic acid) |
HIF |
(hypoxia-inducible factor) |
HC |
(Healhty colon) |
HL |
(Healthy Liver) |
IBD |
(inflammatory bowel disease) |
IFNγ |
(interferon gamma) |
ILs |
(interleukins) |
IM |
(interstitial matrix) |
IME |
(inflammatory microenvironment) |
JNK |
(c-Jun N-terminal kinase) |
LAP |
(latency-associated protein) |
LTBP |
(Latent TGFβ binding protein) |
LAP |
(latency-associated protein) |
LOX |
(lysyl oxidases) |
LOXLs |
(LOX-like proteins) |
MAPK |
(mitogen-activated protein kinase) |
MCs |
(mast cells) |
MT1-MMP |
(membrane-type 1 matrix metalloproteinase) |
MHs |
(microporous hydrogels) |
MIP |
(macrophage inflammatory protein) |
MMPs |
(metalloproteinases) |
MHC |
(Major Histocompatibility Complex) |
MTT |
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) |
MYC |
(myelocytomatosis) |
NETs |
(neutrophil extracellular traps) |
NF-kB |
(nuclear factor kappa-light-chain-enhancer of activated B cells) |
NK |
(natural killer) |
OPN |
(Osteopontin) |
PAI |
(plasminogen activator inhibitor) |
PAMPs |
(pathogen-associated patterns) |
PDAC |
(pancreatic ductal adenocarcinoma) |
PDGF |
(platelet-derived growth factor) |
PDGF-EC |
(platelet derived endothelial cell growth factor) |
PGP |
(Pro-Gly-Pro) |
PGs |
(proteoglycans) |
PPARs |
(peroxisome proliferator-activated receptors) |
PGE2 |
(Prostaglandin E2) |
PTEN |
(Phosphatase and tensin homolog) |
PTPs |
(protein tyrosine phosphatases) |
PVDF |
(polyvinylidene fluoride) |
RA |
(rheumatoid arthritis) |
RNI |
(reactive nitrogen intermediate) |
RNS |
(reactive nitrogen species) |
ROCK1 |
(Rho-associated protein kinase 1) |
ROS |
(reactive oxygen species) |
SDF |
(stromal cell-derived factor 1) |
SERPINE2 |
(serine proteinase inhibitor-E2) |
SIKVAV |
(Ser-Ile-Lys-Val-Ala-Val) |
SRC |
(Proto-oncogene tyrosine-protein kinase) |
TAMs |
(Tumor associated macrophages) |
TANs |
(tumor-associated neutrophils) |
TGF-β |
(transforming growth factor β) |
Th17 |
(T-helper IL-17 producing cells) |
TINKs |
(tumor-infiltrating natural killer cells) |
TIMP |
(tissue inhibitor of metalloproteinases) |
TLRs |
(Toll-like receptors) |
TME |
(tumor microenvironment) |
TNF-α |
(tumor necrosis factor α) |
TNFR |
(tumor necrosis factor receptor superfamily) |
Tregs |
(Regulatory T cells) |
TSPs |
(Thrombospondins) |
VEGF |
(vascular endothelial growth factors) |